Jeffrey J. Hessekiel
General Counsel
Cytokinetics Inc (CYTK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey J. Hessekiel
Jeffrey J. Hessekiel is recorded as General Counsel at Cytokinetics Inc (CYTK). Earlier roles on record: General Counsel at Exelixis, Inc. (EXEL) until November 7, 2025. Cytokinetics Inc reported in an 8-K filed November 14, 2025 that Jeffrey J. Hessekiel was appointed Executive Vice President, Chief Legal and Administrative Officer, effective November 14, 2025. The proxy statement of Exelixis, Inc. reports total compensation of $8,992,592 for Jeffrey J. Hessekiel in fiscal 2025, including a base salary of $672,374. Disclosed compensation is on record for 9 fiscal years.
“On November 13, 2025, Cytokinetics, Incorporated (the "Company") entered into an employment offer letter (the "Offer Letter") with Jeffrey J. Hessekiel, pursuant to which Mr. Hessekiel has agreed to serve as the Company's Executive Vice President, Chief Legal and Administrative Officer, effective as of November 14, 2025 (the "Start Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-11-14–present
-
Cytokinetics Inc (CYTK)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2025-11-07
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cytokinetics Inc
Other people whose current roles at this company are on record from its filings.
- Robert Blum CEO
- Robert I. Blum CEO, Board Member
- John T. Henderson, M.D. Chairman
- Sung H. Lee CFO
- Brett Pletcher General Counsel
- Mark A. Schlossberg General Counsel
- Mr. Schlossberg General Counsel
- Mr. Wong Chief Accounting Officer
- Robert Wong Chief Accounting Officer
- Sung Lee Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Exelixis, Inc. (EXEL) | Former Executive Vice President, General Counsel | $672,374 | $8,992,592 |
| 2025 | Cytokinetics Inc (CYTK) | Executive Vice President, Chief Legal & Administrative Officer | $85,250 | $6,086,217 |
| 2024 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel | $685,882 | $3,736,716 |
| 2023 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel | $657,175 | $4,562,689 |
| 2022 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel | $630,285 | $4,616,110 |
| 2021 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel and Secretary | $599,135 | $2,174,751 |
| 2020 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel and Secretary | $576,091 | $916,910 |
| 2019 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel and Secretary | $553,934 | $838,674 |
| 2018 | Exelixis, Inc. (EXEL) | Executive Vice President and GeneralCounsel | $531,880 | $2,069,716 |
| 2017 | Exelixis, Inc. (EXEL) | Executive Vice President and GeneralCounsel | $507,067 | $3,196,103 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.